Showing results (401-410 of 1,750) with videos related to
Sort By:
Pageof 175
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 10, 2015
Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicityChristian Bauer, Claudia Hees, Alexander Sterzik, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2012
Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer modelCheol-Hun Son, Dong Yeok Shin, Sung-Dae Kim, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2012
Tumor stem cell antigens as consolidative active specific immunotherapy: a randomized phase II trial of dendritic cells versus tumor cells in patients with metastatic melanomaRobert O Dillman, Andrew N Cornforth, Carol Depriest, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-γ and T-cell activation markersJosef Leibold, Judith Feucht, Ameli Halder, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccinationAhmad A Tarhini, Lisa H Butterfield, Yongli Shuai, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 22, 2023
Fecal Microbiota Transplantation for Immune Checkpoint Inhibitor-Induced Colitis Is Safe and Contributes to Recovery: Two Case ReportsBas Groenewegen, Elisabeth M Terveer, Arjen Joosse, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2023
Enhancing Efficacy of TCR-engineered CD4 + T Cells Via Coexpression of CD8αVictoria E Anderson, Sara S Brilha, Anika M Weber, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2022
Prognostic Potential of Metabolic Activity on 18 F-FDG Accumulation in Advanced NSCLC Receiving Combining Chemotherapy Plus PD-1 BlockadeKosuke Hashimoto, Kyoichi Kaira, Hisao Imai, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 15, 2020
The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint InhibitorsFabiana Perrone, Roberta Minari, Melissa Bersanelli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 10, 2022
Brief Communication on the Impact of β-blockers on Outcomes in Patients Receiving Cancer ImmunotherapyOliver John Kennedy, Marianne Therese NearyPageof 175